Trials / Completed
CompletedNCT03636191
The Effect of a Probiotic on Upper Respiratory Tract Infections
The Effect of Lactobacillus Rhamnosus (LGG®) on the Defence Against Pathogens in the Upper Respiratory Tract in Healthy Children - a Single-center, Randomized, Double-blind, Placebo-controlled Study With 16 Weeks Intervention.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 619 (actual)
- Sponsor
- Chr Hansen · Industry
- Sex
- All
- Age
- 2 Years – 6 Years
- Healthy volunteers
- Accepted
Summary
This study is a randomized, double-blind, placebo-controlled, two-armed, parallel-group study in healthy children aged 2-6 years. The study will investigate the effect of daily intake of a probiotic on Upper Respiratory Tract Infections (URTI) during a 16-week intervention.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Probiotic strain | Lactobacillus |
| DIETARY_SUPPLEMENT | Placebo | Placebo |
Timeline
- Start date
- 2018-09-01
- Primary completion
- 2019-04-13
- Completion
- 2019-08-30
- First posted
- 2018-08-17
- Last updated
- 2020-07-10
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT03636191. Inclusion in this directory is not an endorsement.